Last update Dec. 8, 2019
Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
5-[2-(2-Butoxyethoxy)ethoxymethyl]-6-propyl-1,3-benzodioxole is Piperonyl Butoxide in Chemical name.Is written in other languages:
5-[2-(2-Butoxyethoxy)ethoxymethyl]-6-propyl-1,3-benzodioxole belongs to this group or family:
Write us at email@example.com
e-lactancia is a resource recommended by Asociación Española de Bancos de Leche Humana of Spain
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM
Piperonyl butoxide is used as a synergist mixed with piperonyl and pyrethrins or pyrethroids in the treatment of pediculosis, head and body lice and pubis (crabs).
Its cutaneous absorption is minimal, around 2% (Buist 2005, Selim 1999), so it is unlikely that it reaches significant concentrations in breast milk.
Its sporadic use is compatible with breastfeeding.
Avoid applying it on the breast or nipple. Otherwise, cleanse it thoroughly before nursing.